Evidence map›Paper›PMID 15647194›Full record

ArticleGut2005

Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis.

I Nishimori, E Miyaji, K Morimoto, K Nagao, M Kamada, S Onishi

Open access · bronzeAbstract read
In one paragraph

Article in Gut, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Carbonic anhydrases as disease markers.Expert opinion on therapeutic patents · 2019
    Review
  8. [Pathogenesis of immunoglobulin G4-related hepatobiliary disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018
    Article
  9. The Immunologic Paradoxes of IgG4-Related Disease.Clinical reviews in allergy & immunology · 2018
    Review
  10. Review
  11. Current perspectives on autoimmune pancreatitis and IgG4-related disease.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2018
    Review
  12. Review
  13. Article
  14. Article
  15. IgG4-related hepatobiliary disease: an overview.Nature reviews. Gastroenterology & hepatology · 2016
    Review
  16. An overview of the diagnosis and management of immunoglobulin G4-related disease.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016
    Review
  17. Autoimmune pancreatitis.Gland surgery · 2016
    Review
  18. Potential role of Th17 cells in the pathogenesis of type 2 autoimmune pancreatitis.Virchows Archiv : an international journal of pathology · 2015
    Article
  19. Immunology of IgG4-related disease.Clinical and experimental immunology · 2015
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

I NishimoriDepartment of Gastroenterology and Hepatology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan. nisao@med.kochi-u.ac.jp
E Miyaji
K Morimoto
K Nagao
M Kamada
S Onishi
Kochi Medical School Hospital · JPJapan Tobacco (United States) · USKōchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsSerum antibodies to carbonic anhydrase (CA) II have been reported in patients with autoimmune pancreatitis (AIP) and Sjogren's syndrome (SjS). However, their significance in the pathogenesis of these diseases is controversial. The aim of this study was to identify serum antibodies to CA isozymes, which are expressed in ductal cells of the pancreas.

methodsRecombinant proteins of human CAs IV, IX, and XII were obtained using a bacterial expression system, and five CA IV peptides with theoretically high antigenicity were synthesised. Western blotting and enzyme linked immunosorbent assay (ELISA) were used to detect serum antibodies to the CA isozymes.

resultsThe first screening analysis by western blot showed serum antibodies to CA IV among three CA isozymes in patients with idiopathic chronic pancreatitis, including AIP patients. Further analysis by ELISA showed a significantly increased prevalence of serum antibodies to the truncated CA IV protein and the CA IV synthetic peptide (LGS LTT PTC DEK VVW TVF REP I) in patients with definite AIP (4/15 and 6/20, respectively; p<0.01), probable AIP (6/14 and 3/14; p<0.02), and SjS (9/20 and 8/40; p<0.001) compared with normal controls (0/26). There was no significant difference in the antibody prevalence rates between normal controls and patients with alcoholic chronic pancreatitis (2/15 in each) or pancreatic cancer (2/14 and 1/14, respectively). The presence of serum antibodies to the CA IV peptide showed significant correlations with serum gamma-globulin and IgG levels in AIP patients.

conclusionsThese findings suggest that CA IV may be a target antigen that is commonly expressed in epithelial cells of specific tissues involved in AIP and its related diseases.

Indexed as

AgedAutoantibodiesAutoantigensAutoimmune DiseasesCarbonic Anhydrase IVChronic DiseaseEnzyme-Linked Immunosorbent AssayFemaleHumansIsoenzymesMaleMiddle AgedPancreatitisRecombinant ProteinsSjogren's SyndromeAutoantibodiesAutoantigensCarbonic Anhydrase IVIsoenzymesRecombinant Proteins

Identifiers

PMID15647194
PMCPMC1774835
OpenAlexW2110726859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.